Tilavonemab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5125
Add to Compare
$306.00

Tilavonemab Biosimilar - Research Grade

Product Benefits:

ichorbio’s Tilavonemab Biosimilar for Research Use Only (RUO)

Target:

MAPT

Size:

ichorbio’s Tilavonemab Biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg, 50mg, 100mg

Isotype:

Human IgG4(S228P)-Kappa

Host:

CHO Cells

Species Reactivity:

Human

Specificity:

Detects human MAPT.

Purification Method:

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Concentration:

5mg/ml

Formulation:

Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity:

>95% by SDS-PAGE

Endotoxin:

≤ 1.0 EU/mg as determined by the LAL method

Storage:

This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.

Applications:

Functional Assays

Application Notes:

This biosimilar is strictly for research use only (RUO).

More Information
Concentration 5.07mg/ml
Isotype Human IgG4(S228P)-Kappa
Host CHO Cells
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Application Notes This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Applications Functional Assays
Storage This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Endotoxin <1EU/mg Determined by LAL gel clotting assay
Purity ≥95% monomer by analytical SEC, >95% by SDS Page
Formulation Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purification Method This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Specificity Detects human MAPT
Species Reactivity Human
Target Tau
Shipping Conditions Blue ice
background Uses the same sequence as the therapeutic antibody Tilavonemab
Other names MAPT
Buffer ICH3002
Sequence https://www.imgt.org/mAb-DB/
Write Your Own Review
You're reviewing:Tilavonemab Biosimilar - Research Grade
Your Rating
Back to Top